Li Gan, PhD, wants to find treatments to help patients with Alzheimer’s disease. Like most researchers, she’s hit a few major roadblocks.
When researchers like Gan find potential new drugs, it’s useful to test them on human cells to increase the chances that they will benefit patients. Historically, these tests have been conducted in cancer cells, which often don’t match the biology of human brain cells.
“The problem is that brain cells from actual people don’t survive well in a dish, so we need to engineer human cells in the lab,” explained Gan, senior investigator at the Gladstone Institutes. “But, that’s not as simple as it may sound.”
Many scientists use induced pluripotent stem cells (iPSCs) to address this issue. IPSCs are made by reprogramming skin cells or blood cells to become stem cells, which can then be transformed into any type of cell in the body. Gan uses iPSCs to produce brain cells, such as neurons or glial cells, because they are relevant to neurodegenerative disease.
Human brain cells derived from iPSCs offer great potential for drug screening. Yet, the process for producing them can be complicated, expensive, and highly variable. Many of the current methods produce cells that are heterogeneous, or different from one another, and this can lead to inconsistent results in drug screening. In addition, producing a large number of cells is very costly, so it’s difficult to scale up for big experiments.
A new platform developed in Gan’s lab will now allow scientists to overcome these constraints
A New Technique Is Born
“I came across a new method to produce iPSCs that was developed at Stanford,” said Michael Ward, MD, PhD, a former staff scientist in Gan’s lab who is now an investigator at the National Institutes of Health. “I thought that if our team could find a way to simplify and better control that approach, we might be able to improve the way we engineer human brain cells in the lab.”
Ward and his colleague Chao Wang, PhD, discovered a way to manipulate the genetic makeup of cells to produce thousands of neurons from a single iPSC. This meant that every engineered brain cell was now identical.
“I was truly motivated by our initial results,” said Gan, who is also a professor of neurology at UC San Francisco. “I had observed too much variability using the traditional methods, which made reproducing experiments quite problematic. So, the ability to produce homogeneous human brain cells was very exciting.”
The team further improved the technique to create a simplified, two-step process. This allows scientists to precisely control how many brain cells they produce and makes it easier to replicate their results from one experiment to the next.
Their technique also greatly accelerates the process. While it would normally take several months to produce brain cells, Gan and her team can now engineer large quantities of them within 1 or 2 weeks, and have functionally active neurons within 1 month.
The researchers realized this new approach had tremendous potential to screen drugs and to study disease mechanisms. To prove it, they tested it in their own research.
They applied their technique to produce human neurons by using iPSCs. Then, they developed a drug discovery platform and screened 1,280 compounds. Their goal is to identify the compounds that could lower levels of the protein tau in the brain, which is considered one of the most promising approaches in Alzheimer’s research and could potentially lead to new drugs to treat the disease.
“We showed that we can engineer large quantities of human brain cells that are all the same, while also significantly reducing the costs,” said Wang, Gladstone postdoctoral scholar. “This means our technology can easily be scaled up and can essentially be used to screen millions of compounds.”
A Powerful Tool for the Entire Scientific Community
“We have developed a cost-effective technology to produce large quantities of human brain cells in two simple steps,” summarized Gan. “By surmounting major challenges in human neuron-based drug discovery, we believe this technique will be adopted widely in both basic science and industry.”
Word of this useful new technology has already spread, and people from different scientific sectors have come knocking on Gan’s door to learn about it. Her team has shared the new method with scores of academic colleagues, some of whom had no experience with cell culture. So far, they all successfully repeated the two-step process to produce their own cells and facilitate scientific discoveries.
Details of this new technique were published on October 10, 2017, in the scientific journal Stem Cell Reports.
With some of the roadblocks out of the way, Gan hopes more discoveries will soon help the millions who suffer from Alzheimer’s disease and related conditions.
Learn more: Growing Human Brain Cells in the Lab
The Latest on: Drug discovery
- Corbus Pharmaceuticals licenses worldwide rights for more than 600 compounds from Jenrin Discovery on September 20, 2018 at 5:46 am
manufacture and market drug candidates from more than 600 compounds targeting the endocannabinoid system from Jenrin Discovery LLC. The pipeline consists of CRB-4001 which includes multiple ... […]
- Cambridge duo in £1m AI drug discovery project on September 20, 2018 at 4:14 am
Cambridge duo Optibrium and Intellegens along with Medicines Discovery Catapult in Cheshire have secured a grant from Innovate UK to fund a £1 million project investigating Artificial Intelligence sup... […]
- Advancements in Pressure Sensors, Cancer Diagnosis, Implantable Devices, Drug Discovery, and Humidity Control - ResearchAndMarkets.com on September 20, 2018 at 2:35 am
The "Advancements in Pressure Sensors, Cancer Diagnosis, Implantable Devices, Drug Discovery, and Humidity Control" report has been added to ResearchAndMarkets.com's offering. This edition of the Insi... […]
- ALSAM Foundation invests additional $2 million for drug discovery and development projects on September 20, 2018 at 1:18 am
The ALSAM Foundation recently invested an additional $2 million to continue the Therapeutic Innovation Grants Program at the CU Skaggs School of Pharmacy and Pharmaceutical Sciences. The funding suppo... […]
- Drug Discovery Informatics Market Research Report by Key Players Analysis 2025 on September 19, 2018 at 1:19 pm
The "Global Drug Discovery Informatics Market Analysis to 2025" is a specialized and in-depth study of the drug discovery informatics industry with a focus on the global market trend. The report aims ... […]
- Drug Discovery Platform Verseon Launches Blockchain-Based Securities Exchange on September 18, 2018 at 5:41 am
U.S. pharmaceutical company Verseon has become the latest medical organization to experiment in blockchain technology, it confirmed in a press release Tuesday, September 18. Verseon’s main ... […]
- Fujitsu Technology to Solve Combinatorial Optimization Problems for Medium-Sized Drug Discovery on September 17, 2018 at 10:46 pm
News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here. TOKYO, Sept 18, 2018 - (JCN Newswire) - - Fujitsu Laboratories Ltd. today ann... […]
- Dr. Michela Gallagher Wins Alzheimer's Drug Discovery Foundation's Prestigious Melvin R. Goodes Prize on September 17, 2018 at 6:08 am
NEW YORK, Sept. 17, 2018 /PRNewswire/ -- Dr. Michela Gallagher has been named the recipient of the 2018 Melvin R. Goodes Prize for Excellence in Alzheimer's Drug Discovery. The prize, awarded by the A... […]
- Aclaris Therapeutics to Highlight Drug Discovery Targeting the Human Kinome at 16th Annual Discovery on Target Meeting on September 17, 2018 at 4:00 am
The abstracts will be available in the conference program book. One poster describes Aclaris’ proprietary KINect™ platform for human protein kinase cysteinome drug discovery. Many human ... […]
- Vertex’s David Altshuler Humanizes Drug Discovery on September 13, 2018 at 12:35 pm
Dr. David Altshuler speaking at the Advances in Genome Biology and Technology meeting. [AGBT] To kick off the Advances in Genome Biology and Technology (AGBT) precision health meeting held in La Jolla ... […]
via Google News and Bing News